The VITROS Immunodiagnostic Products SARS-CoV-2 Antigen test delivers fast, high-volume testing for active infection with excellent specificity and sensitivity, making it a viable alternative to PCR testing.
The VITROS Immunodiagnostic Products SARS-CoV-2 Antigen test is manufactured in Great Britain by Ortho-Clinical Diagnostics and was approved by Health Canada on May 10, 2021.
If your company or organization is interested in rapid testing solutions, contact us today for help procuring the VITROS Immunodiagnostic Products SARS-CoV-2 Antigen test or other rapid tests approved by Health Canada. Our team at Rapid Test & Trace Canada can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
ABOUT US
RESOURCES